Study of Dermal Interstitial Fluid Collection With a Vacuum-Assisted Microneedle Device
MAP
1 other identifier
interventional
50
1 country
1
Brief Summary
This study evaluates the collection of dermal interstitial fluid using a vacuum-assisted microneedle device in healthy adult volunteers. The study will assess the device-based collection procedure and characterize the collected dermal interstitial fluid. Healthy adult volunteers will undergo dermal interstitial fluid collection using a vacuum-assisted microneedle device at the Stanford study site. Participants will complete the study procedures described in the protocol, which may include device application, vacuum-assisted microneedle sampling, collection and analysis of dermal interstitial fluid, assessment of procedure-related effects, and follow-up as specified by the study protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Oct 2026
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2030
October 9, 2026
October 1, 2026
1.9 years
October 1, 2026
October 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Volume of Dermal Interstitial Fluid Collected
Volume of dermal interstitial fluid obtained using the vacuum-assisted microneedle device, measured in microliters. Collection performance will be evaluated for the device configuration used during each participant's study visit.
Baseline
Secondary Outcomes (1)
Participant-Reported Pain Associated With Device Use,Reported Ability to Operate the Device With Minimal Assistance and safety
Baseline and up to 30 days.
Study Arms (1)
Vacuum-Assisted Microneedle Interstitial Fluid Collection
EXPERIMENTALHealthy adult volunteers aged 18 years or older will undergo dermal interstitial fluid collection using a vacuum-assisted microneedle device during a single study visit. Each participant will receive one device configuration selected according to the current stage of device development. Collection typically lasts 5 minutes and will not exceed 30 minutes per attempt. With participant permission, collection may be repeated up to twice at different skin sites if the amount collected is insufficient. Participants will receive instructions to report delayed device-related adverse events occurring within 30 days
Interventions
The device comprises an adhesive alignment plate, an applicator containing a microneedle array patch, and a porous dome connected to a pre-evacuated collection tube. The patch is applied to the skin and immediately removed with the applicator. Vacuum then draws dermal interstitial fluid into the dome. Collection typically lasts 5 minutes, with a maximum of 30 minutes per attempt and an expected yield of approximately 15 microliters. Up to two additional collections at different skin sites are permitted with participant permission if the yield is insufficient. Configurations may use different-size collection tubes; flat domes or domes with different curvature radii; and aligned-perforation or triply periodic minimal surface lattice geometries. Each participant receives one configuration.
Eligibility Criteria
You may qualify if:
- years of age or older.
- Willing to undergo microneedle array patch (MAP) application.
You may not qualify if:
- History of skin conditions that predispose the participant to adverse reactions to skin puncture. Examples include eczema, psoriasis, and keloids.
- Active infection, open wound, rash, or skin breakdown on the arm being used for MAP device application.
- Known allergy to acrylate or device materials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sharon Pitterilead
- Stanford Universitycollaborator
Study Sites (1)
Stanford University
Stanford, California, 94305, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor (Research) of Radiology (Diagnostic Sciences Laboratory)
Study Record Dates
First Submitted
October 1, 2026
First Posted
October 9, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2030
Last Updated
October 9, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share